The provided blog post focuses on India’s participation in an international meeting concerning the regulation of herbal medicines. While the topic is interesting, it doesn’t directly align with most of the medical specialities listed. However, there’s a general theme of **traditional medicine** and **regulation of medical products**, which could be tangentially related to some courses.
Given the content, the most relevant “catch-all” category would be **Pharmacy Speciality Courses** as it deals with drug regulation and development, albeit from a broader perspective than just herbal medicines. Alternatively, a general health or regulatory course might be more fitting if such a category existed.
Since the instruction is to provide at least one link and to tag the nearest specialty page if no direct match exists, linking to the “Pharmacy Speciality Courses” page is the most sensible option.
Here’s the modified HTML:
India actively showcased its advanced evidence-based initiatives and a robust regulatory framework for herbal medicine regulation at the 16th World Health Organization-International Regulatory Cooperation for Herbal Medicines (WHO-IRCH) meeting. This significant international gathering of global authorities and experts took place in Jakarta, Indonesia. The WHO-IRCH annual meeting primarily aims to enhance international cooperation. Furthermore, it seeks to foster harmonisation in regulatory practices for herbal medicines. India’s evolving approaches certainly highlight its commitment to global health standards.
Dr. Raghu Arackal, an Advisor from the Union Ministry of Ayush, led the Indian delegation. This delegation played a pivotal role throughout the event. Indeed, their participation was particularly prominent during the technical sessions. These sessions occurred from October 14-16, providing an essential platform for sharing India’s extensive experience.
India’s Contributions to Herbal Medicine Regulation
Notably, two crucial workshops preceded the WHO-IRCH meeting. The WHO and the Ministry of Ayush jointly organized and hosted these workshops. They received support from the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H). Specifically, these events took place in Ghaziabad, India, from August 6th to 8th, 2025. They served as vital preparatory inputs. These collaborative efforts, furthermore, demonstrate India’s dedication to international regulatory alignment.
During the meeting, Dr. Raghu Arackal presented the Workshop Report on Efficacy and Intended Use of Herbal Medicines (Working Group-3). He clearly highlighted India’s progressive regulatory framework and its evidence-based policy initiatives in traditional medicine. Moreover, Dr. Raman Mohan Singh, Director of PCIM&H, delivered the Workshop Report on Safety and Regulation of Herbal Medicines (Working Group-1). He also provided a separate presentation: “Safety and Regulation of Herbal Medicines-Indian Perspective.” This offered profound insights into national practices. Additionally, Dr. Mahesh Dadhich, CEO of the National Medicinal Plants Board (NMPB), co-presented a session with Dr. Raman. This session focused on Quality Control, Standardisation, and Sustainability of Herbal Medicines. Consequently, their combined presentations comprehensively covered crucial aspects of herbal medicine oversight.
Dr. Dadhich further contributed to important discussions concerning the sustainable use of medicinal plants. He also emphasised the critical importance of international collaboration. This collaboration, in turn, guarantees quality control and standardisation across the globe. Therefore, the comprehensive contributions from the Indian delegation strongly underscore India’s significant role. It shows India’s commitment to shaping global standards for the quality, safety, and efficacy of herbal medicines, benefiting both practitioners and patients worldwide. For professionals interested in the regulatory aspects of medicine, exploring Pharmacy speciality courses may offer valuable insights.
Frequently Asked Questions
Q1: What was the main purpose of the 16th WHO-IRCH meeting?
The primary purpose was to strengthen international cooperation and harmonisation in the regulation of herbal medicines.
Q2: Who led the Indian delegation at the WHO-IRCH meeting?
Dr. Raghu Arackal, Advisor from the Union Ministry of Ayush, led the Indian delegation.
Q3: Which key preparatory workshops were held before the main meeting?
Two workshops, jointly organised by WHO and hosted by the Ministry of Ayush, were held in Ghaziabad from August 6-8, 2025, focusing on efficacy, intended use, safety, and regulation of herbal medicines.
References
- India showcases evidence-based initiatives in traditional medicine at 16thWHO-IRCH meeting – ETHealthworld
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.